TB-500

Thymosin beta 4: a ubiquitous peptide in rat and mouse tissues

Chemical characterization of thymosin beta 4

Thymosin β(4) and β(10) Expression in Human Organs during Development: A Review

Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies

Thymosin beta 4 and the eye: the journey from bench to bedside

Thymosin beta 4 regulation of actin in sepsis

Sources of variability in quantifying circulating thymosin beta-4: literature review and recommendations

Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease

Cardioprotection by Thymosin Beta 4

Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells

Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy, Dry Eye, and Ocular Surface Diseases

Potential role of thymosin Beta 4 in liver fibrosis

Adhesive and proteolytic phenotype of migrating endothelial cells induced by thymosin beta-4

Thymosin beta-4 and the eye: I can see clearly now the pain is gone

Thymosin beta-4 is essential for coronary vessel development and promotes neovascularization via adult epicardium

Thymosin beta 4 interactions

Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications

Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies

Doping control analysis of TB-500, a synthetic version of an active fragment of thymosin β₄.

Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids

Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion

Thymosin Beta-4 Modulates Cardiac Remodeling by Regulating ROCK1 Expression in Adult Mammals

Enhancing fat graft survival: thymosin beta-4 facilitates mitochondrial transfer from ADSCs via tunneling nanotubes by upregulating the Rac/F-actin pathway

Thymosin beta-4 participate in antibacterial immunity and wound healing in black tiger shrimp, Penaeus monodon

Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways

Thymosin beta 4: A potential novel adjunct treatment for bacterial keratitis

Thymosin beta 4 prevents systemic lipopolysaccharide-induced plaque load in middle-age APP/PS1 mice

Thymosin Beta 4 Protects Hippocampal Neuronal Cells against PrP (106-126) via Neurotrophic Factor Signaling

Thymosin beta-4 - A potential tool in healing middle ear lesions in adult mammals

Aberrant Expression of Thymosin Beta-4 Correlates With Advanced Disease and BRAF V600E Mutation in Thyroid Cancer

Thymosin beta-4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells

Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during Pseudomonas aeruginosa-Induced Corneal Infection

Thymosin beta4 accelerates wound healing

Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development.

Adsorption effects of the doping relevant peptides Insulin Lispro, Synachten, TB-500 and GHRP 5

Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential

Thymosin β4 Promotes Dermal Healing

A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers